Navigation Links
Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation
Date:7/29/2008

- Unsuccessful Phase III Study Does Not Mean the End of Anti-Amyloid Therapies -

CHICAGO, July 29 /PRNewswire-USNewswire/ -- Results from four studies of potential new treatments for Alzheimer's - even an unsuccessful late stage clinical trial - increase the field's knowledge and point scientists toward advances in therapies for the disease, according to research reported today at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease (ICAD 2008), in Chicago.

The reports included data from:

-- A Phase III trial of tarenflurbil (Flurizan, Myriad), an anti-amyloid therapy, that failed to achieve its primary endpoints.

-- A 12-week, Phase IIa trial of PBT2 (Prana Biotechnology), which reduces the toxic form of amyloid by preventing the interaction of amyloid with copper and zinc in the brain.

-- A 84-week, Phase II trial of methylthioninium chloride (rember(TM), TauRx Therapeutics), a tau aggregation inhibitor that targets toxic tau aggregates, or "tangles." Tangles of tau in the brain are another characteristic hallmark of Alzheimer's.

-- A proof of concept clinical trial in mild Alzheimer's of Souvenaid (Danone Research-Centre for Specialised Nutrition), a "medical food" product that encourages the formation of brain synapses and may reduce beta amyloid.

"While researchers continue to investigate amyloid as a target for Alzheimer's therapies - it is the most mature theory being pursued - we must also examine other potential avenues given the urgency of conquering this disease," said Samuel Gandy, MD, Ph.D., chair of the Alzheimer's Association's Medical and Scientific Advisory Council. "We can't leave any stone unturned if we hope to aid the 5 million people currently living with Alzheimer's and the millions more that will be devastated by this epidemic."

While currently approved treatment options for Alzheimer's offer some relief of symptoms for perhaps a year or two, they do no
'/>"/>

SOURCE Alzheimer's Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
2. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
4. Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation
5. Controversy About Lack of Placebo Group Decline in Alzheimers Clinical Trials
6. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
7. Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer
8. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
9. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
10. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
11. Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... -- TWi Pharmaceuticals, Inc. (4180.TT) today announced that it ... Food and Drug Administration (FDA) on its Abbreviated ... oral suspension, the generic equivalent to Par Pharmaceutical,s ... Hatch Waxman rules, it will be entitled to ... the pre-launch preparation of the generic drug.  However, ...
(Date:8/27/2014)... About 8 million Americans have peripheral arterial ... fatty plaque in the arteries, according to recent statistics. ... in incidences of diabetes and obesity, the Society ... Arterial RevascularizatioN (LEARN) meeting, Oct. 9–11 in ... residents and fellows will be able to gain state-of-the-art ...
(Date:8/27/2014)... --  Los Angeles orthodontics expert, Dr. Isaac ... want to make their treatment even faster. With this ... patients have a powerful tool to use as they ... by most patients with all types of braces, letting ... AcceleDent® Aura system for a few minutes each day. ...
Breaking Medicine Technology:TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Los Angeles Orthodontist, Dr. Isaac Hakim, is Now Offering AcceleDent Aura 2
... 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") ... in-vitro diagnostic ("IVD") company, today announced that Chengxuan, a ... Chairman and Chief Executive Officer of the Company, informed ... American Depositary Shares ("ADSs") in the open market on ...
... of Disabled Adults and Children (FODAC) has partnered with Invacare ... of equipment and supplies to Joplin, Missouri. A massive F5 ... 2011, leaving much of the city in ruins. FODAC, with ... supply shipment to Joplin within 24 hours of the disaster. ...
Cached Medicine Technology:China Medical Technologies Announces the Purchase of its ADSs by Chengxuan in the Open Market 2Friends of Disabled Adults and Children Partners With Invacare to Provide Aid in Wake of Joplin Tornado 2Friends of Disabled Adults and Children Partners With Invacare to Provide Aid in Wake of Joplin Tornado 3
(Date:8/27/2014)... 2014 DiaSorin has announced that their ... Dihydroxyvitamin D,” will feature guest speaker Dr. Gregory A. ... for Health and Healing Integrative Medicine. Dr. Plotnikoff serves ... Institute for Health and Healing and as Senior Consultant, ... Minnesota. He also serves as a co-editor of the ...
(Date:8/27/2014)... Recently, Skmen.com, a renowned garment manufacturer and ... bodycon dresses . The company has rich experience in ... items in stock and ready to ship: celebrity bodycon ... sweater dresses and so forth. All of them are ... “We are proud to announce the new collection of ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Taking its popular ... Steele Creek YMCA will host its largest crowd ... on Saturday, September 13 at YMCA Camp Thunderbird . ... race divisions: adult, youth and teams. Within each division, ... to their physical limit - for a worthy cause. ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Today, Zane ... webinar on compliance tips for administering a premium reimbursement ... reform in full effect, compliance is top of mind ... transition to individual health insurance and premium reimbursement, there ... , In the 35 minute webinar, Zane Benefits President, ...
(Date:8/27/2014)... Skirt Sports , the innovative women’s ... pioneer runner, Kathrine Switzer, most noted for her brave running ... a line of women’s running clothes that unites the history ... 261 Fearless Movement. , “It is such an ... DeBoom. “Kathrine is the original Skirt – she stood ...
Breaking Medicine News(10 mins):Health News:DiaSorin Announces New Webinar in Their Annual Vitamin D Series 2Health News:DiaSorin Announces New Webinar in Their Annual Vitamin D Series 3Health News:Skmen.com Unveils Its New Celebrity Bodycon Dresses for Its Loyal Customers 2Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2Health News:Zane Benefits Announces Upcoming Webinar on Compliance 2Health News:Skirt Sports Launches Clothing Line with Legendary Runner Kathrine Switzer 2
... ... through its ActiveBase Security™ solution, today announced it has been included in the list of ... Joseph Feiman, Neil MacDonald, John Pescatore, Earl Perkins April 14, 2010, by Gartner Inc. ... Tel Aviv, Israel (PRWEB) April ...
... cases stem from established risk factors, study finds, , ... to increase the odds of breast cancer in white women ... , For instance, for postmenopausal women in the study, "recent ... to play as big a role in Hispanics," said Dr. ...
... ... Spearhead Company,s Quality, Regulatory and Compliance Matters , ... Panama City, Fla. (PRWEB) April 26, 2010 -- ... appointment of Samuel Patton as the company’s chief quality and regulatory officer. He will ...
... ... publishes new e-book that helps people choose the right dentist to perform dental implant surgery. ... (PRWEB) April 26, ... launched her newest e-book, Dental Implants: The Five Questions You Must Ask Your ...
... ... announced a small business Internet video advertising program that can deliver first ... required for traditional web page search engine optimization. The Site Steering small ... promotional video, and using a proprietary method to distribute the video to ...
... BMJ , Nigel Hawkes, freelance journalist and Director of Straight ... investigates how the way that patients are allocated diagnostic codes ... hospital,s performance. It follows two articles published by ... rates to judge hospital performance is a bad idea. ...
Cached Medicine News:Health News:Leading Industry Analyst Firm Names ActiveBase "Cool Vendor" 2Health News:Leading Industry Analyst Firm Names ActiveBase "Cool Vendor" 3Health News:Leading Industry Analyst Firm Names ActiveBase "Cool Vendor" 4Health News:Breast Cancer Risks Not Same for Hispanic Women 2Health News:Breast Cancer Risks Not Same for Hispanic Women 3Health News:iSirona Appoints Chief Quality and Regulatory Officer to Oversee Quality Initiatives 2Health News:New E-Book Explains the Facts About Dental Implants 2Health News:Site Steering Launches Keyword Targeted Small Business Internet Video Advertising Program That Achieves First Page Search Results Within Days 2Health News:Site Steering Launches Keyword Targeted Small Business Internet Video Advertising Program That Achieves First Page Search Results Within Days 3Health News:Is patient coding making hospitals appear better than they are? 2
... Captia Borrelia burgdorferi (B. burgdorferi) IgG/IgM Enzyme ... the qualitative presumptive (firststep) detection of total ... serum. This ELISA should only be used ... are consistent with Lyme disease. Equivocal or ...
POLYSORB™ sutures are composed of LACTOMER™ glycolide/lactide copolymer which is a synthetic polyester composed of glycolide and lactide (derived from glycolic and lactic acids)....
SURGIPRO™ BLUE Monofilament Suture in two sizes....
Surgitie&trade Single Use Ligating Loops with Delivery System...
Medicine Products: